Intrua Financial LLC Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Posted by Defense World Staff on Mar 31st, 2023

Intrua Financial LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 6,123 shares of the pharmacy operator’s stock, valued at approximately $217,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Vontobel Holding Ltd. increased its holdings in Walgreens Boots Alliance by 104.6% during the 1st quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock worth $1,752,000 after acquiring an additional 18,879 shares during the period. Moors & Cabot Inc. increased its holdings in Walgreens Boots Alliance by 31.1% during the 1st quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock worth $931,000 after acquiring an additional 4,931 shares during the period. Sequoia Financial Advisors LLC increased its holdings in Walgreens Boots Alliance by 27.9% during the 1st quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock worth $339,000 after acquiring an additional 1,651 shares during the period. Candriam Luxembourg S.C.A. increased its holdings in Walgreens Boots Alliance by 0.5% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after acquiring an additional 310 shares during the period. Finally, Baird Financial Group Inc. increased its holdings in Walgreens Boots Alliance by 14.2% during the 1st quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock worth $20,932,000 after acquiring an additional 58,184 shares during the period. Institutional investors own 56.71% of the company’s stock.

Walgreens Boots Alliance Trading Up 1.4 %

Shares of WBA opened at $34.63 on Friday. The stock has a market capitalization of $29.87 billion, a P/E ratio of -9.49, a PEG ratio of 1.50 and a beta of 0.72. The company has a quick ratio of 0.36, a current ratio of 0.63 and a debt-to-equity ratio of 0.30. The firm has a fifty day simple moving average of $35.30 and a two-hundred day simple moving average of $36.31. Walgreens Boots Alliance, Inc. has a twelve month low of $30.39 and a twelve month high of $48.48.

Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last announced its quarterly earnings results on Tuesday, March 28th. The pharmacy operator reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.06. The business had revenue of $34.86 billion during the quarter, compared to analysts’ expectations of $33.56 billion. Walgreens Boots Alliance had a negative net margin of 2.36% and a positive return on equity of 12.42%. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.59 EPS. On average, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.51 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 10th. Shareholders of record on Thursday, February 16th were given a dividend of $0.48 per share. The ex-dividend date of this dividend was Wednesday, February 15th. This represents a $1.92 annualized dividend and a yield of 5.54%. Walgreens Boots Alliance’s payout ratio is currently -52.60%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a report on Thursday, March 16th. They set a “hold” rating on the stock. Credit Suisse Group decreased their price target on shares of Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating on the stock in a report on Friday, January 6th. Barclays decreased their price target on shares of Walgreens Boots Alliance from $45.00 to $43.00 in a report on Sunday, March 26th. Mizuho reissued a “neutral” rating and issued a $41.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday. Finally, Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $39.00 to $37.00 and set an “underweight” rating on the stock in a report on Monday, January 30th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $43.07.

About Walgreens Boots Alliance

(Get Rating)

Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.